Abstract
The U.S. cold, flu, and allergy remedies market relies heavily on new product innovation. Greatly influenced by seasonal rhythms and the rising cost of healthcare, the market changes dramatically with changes in vaccines and in the prescription market.
This report will help you understand:
- The huge impact of prescription to over-the-counter switches in tablets, including Claritin and the impending migration of Zyrtec.
- The effect of the 2006 Stop Meth Act, which moved pseudoephedrine products behind the counter, inconveniencing customers and highlighting potential dangers of over-the-counter remedies.
- Activity from the seven leading remedy manufacturers, and the effect of the Johnson & Johnson/Pfizer merger on the supply chain and advertising/promotional strategies.
- The retail landscape, dominated by the drug channel, and the attempts of food and mass channels to adopt similar pharmaceutical services.
- Close inspection of consumer behavior regarding remedies and the conditions they treat, yielding ideas about how manufacturers can increase usage and penetration.
Moreover, this report features in-depth analysis of the future of the market, including potential of and competition from alternative remedies; the impact of voluntary withdrawal of infants' remedies; and the threat of FDA findings which may limit or stop sales of children' s remedies.
Not covered in this report are lozenges, medicated sweets, and products for the relief of coughs and sore throats.
| 
View Cart
